Bradley P Graw, MD
Sports Medicine · San Carlos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 14
- 2 carriers
- Office
- 1
On the public record
- Owns SOAR Surgery Center: Accreditation Lapsed
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 057007 · 058123 · 757662 · Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Graw’s office at (650) 321-4121 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A104283 · Current
Licensed to practise in California · since 2008 · expires 2028-06-30 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- SOAR Surgery CenterBurlingame, CA12.5% owner since 2010 · accredited by IMQAccreditation Lapsed1 inspection · last 2011-05-06
- SOAR Surgery Center, LLCAmbulatory Surgery Center · Burlingame, CA11.1% owner · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$342,794
Medicare paid this office $342,794 for 651 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 72 | $89,995 | $1,154 |
| Replacement of thigh bone and hip joint with prosthesis | 60 | $70,535 | $1,156 |
| Return visit (30+ min) | 249 | $37,742 | $115 |
| Short return visit (20+ min) | 271 | $29,176 | $82 |
| Long return visit (40+ min) | 134 | $22,892 | $165 |
See all 19 services
| Replacement of knee joint, both sides of knee | 72 | $89,995 | $1,154 |
| Replacement of thigh bone and hip joint with prosthesis | 60 | $70,535 | $1,156 |
| Return visit (30+ min) | 249 | $37,742 | $115 |
| Short return visit (20+ min) | 271 | $29,176 | $82 |
| Long return visit (40+ min) | 134 | $22,892 | $165 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 70 | $13,440 | $184 |
| New patient visit (45+ min) | 77 | $11,836 | $154 |
| Telephone medical discussion with physician, 11-20 minutes | 98 | $7,884 | $72 |
| Aspiration and/or injection of fluid from large joint | 92 | $7,552 | $65 |
| New patient visit (60+ min) | 37 | $7,520 | $203 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 270 | $4,952 | $15 |
| New patient visit (30+ min) | 49 | $4,738 | $97 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 52 | $4,456 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,076 | $99 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $2,708 | $97 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 15 | $2,696 | None |
| Telephone medical discussion with physician, 5-10 minutes | 51 | $2,649 | $47 |
| Short return visit | 16 | $835 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 57 | $208 | None |
Procedures Medicare counted
| Hip replacement | 102 | More than 97% of doctors who do this |
| Knee replacement | 94 | More than 92% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
651 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 10% · Women 64% · Also on Medicaid 5% · Health risk score 0.78. At or below the middle of the specialty; the typical sports medicine clinician is at 1.05.
Conditions among them: High blood pressure 61% · Coronary heart disease 22% · Diabetes 17% · Cancer 15% · Atrial fibrillation 14% · Depression 14% · Chronic kidney disease 13% · Heart failure 8% · COPD 7% · Stroke 4% · Dementia 2%.
The office billed $1,650,013, Medicare allowed $441,807 and paid $342,794; for 2,418 services of 42 kinds; $3,020 of it was for drugs given in the office and $339,774 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 651 | 2,418 | 75 | 0.78 | $1,650,013 | $342,794 |
| 2023 | 617 | 1,891 | 75 | 0.79 | $1,326,734 | $291,007 |
| 2022 | 552 | 1,450 | 75 | 0.81 | $1,123,996 | $248,876 |
| 2021 | 585 | 1,805 | 75 | 0.82 | $1,210,170 | $273,538 |
| 2020 | 461 | 1,652 | 75 | 0.89 | $1,069,967 | $235,451 |
| 2019 | 565 | 1,733 | 75 | 0.97 | $1,056,645 | $238,006 |
| 2018 | 583 | 2,184 | 76 | 1.06 | $1,109,134 | $242,512 |
| 2017 | 573 | 2,115 | 75 | 1.06 | $950,009 | $225,327 |
| 2016 | 246 | 828 | 74 | 0.96 | $304,028 | $75,723 |
| 2015 | 16 | 26 | 65 | 1.01 | $26,159 | $4,997 |
| 2014 | 222 | 956 | 76 | 1.10 | $266,656 | $74,272 |
| 2013 | 358 | 2,416 | 75 | 1.07 | $558,472 | $168,787 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Replacement of knee joint, both sides of knee | 60 | $72,135 | $1,163 |
| Replacement of thigh bone and hip joint with prosthesis | 52 | $63,803 | $1,182 |
| Return visit (30+ min) | 278 | $39,339 | $113 |
| Long return visit (40+ min) | 115 | $21,087 | $162 |
| Short return visit (20+ min) | 214 | $20,919 | $78 |
| New patient visit (45+ min) | 90 | $13,359 | $148 |
| Aspiration and/or injection of fluid from large joint | 99 | $10,513 | $71 |
| New patient visit (60+ min) | 46 | $9,489 | $206 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 36 | $8,306 | None |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 25 | $4,901 | $182 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $3,145 | $112 |
| Short return visit | 51 | $3,143 | $52 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 35 | $3,140 | $87 |
| New patient visit (30+ min) | 31 | $3,067 | $99 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $2,147 | $89 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $503 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 77 | $336 | None |
2022: 14 services
| Replacement of thigh bone and hip joint with prosthesis | 54 | $65,837 | $1,155 |
| Replacement of knee joint, both sides of knee | 51 | $61,260 | $1,156 |
| Return visit (30+ min) | 222 | $32,407 | $117 |
| Short return visit (20+ min) | 214 | $20,922 | $80 |
| Long return visit (40+ min) | 73 | $12,960 | $164 |
| New patient visit (45+ min) | 79 | $10,951 | $139 |
| Aspiration and/or injection of fluid from large joint | 99 | $9,894 | $69 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 32 | $8,233 | None |
| New patient visit (30+ min) | 75 | $7,546 | $101 |
| Short return visit | 40 | $2,336 | $54 |
| New patient visit (60+ min) | 11 | $2,134 | $194 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,314 | $110 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,060 | $76 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 67 | $202 | None |
2021: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 55 | $67,293 | $1,181 |
| Replacement of knee joint, both sides of knee | 45 | $55,187 | $1,174 |
| Return visit (30+ min) | 215 | $31,367 | $119 |
| Short return visit (20+ min) | 258 | $30,910 | $82 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 66 | $19,769 | None |
| Aspiration and/or injection of fluid from large joint | 136 | $17,240 | $69 |
| New patient visit (30+ min) | 137 | $13,513 | $99 |
| New patient visit (45+ min) | 73 | $10,820 | $148 |
| Long return visit (40+ min) | 53 | $9,790 | $169 |
| Short return visit | 45 | $2,960 | $56 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 14 | $1,598 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | $187 | None |
2020: 14 services
| Replacement of knee joint, both sides of knee | 42 | $59,853 | $1,247 |
| Replacement of thigh bone and hip joint with prosthesis | 45 | $57,710 | $1,255 |
| Short return visit (20+ min) | 237 | $22,517 | $67 |
| Return visit (30+ min) | 162 | $18,387 | $96 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 38 | $13,978 | None |
| Aspiration and/or injection of fluid from large joint | 106 | $12,742 | $66 |
| New patient visit (30+ min) | 84 | $7,538 | $90 |
| Long return visit (40+ min) | 43 | $5,709 | $133 |
| New patient visit (45+ min) | 33 | $4,649 | $141 |
| Telephone medical discussion with physician, 11-20 minutes | 38 | $2,883 | $72 |
| Short return visit | 42 | $2,045 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 37 | $1,711 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,275 | $106 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 74 | $381 | None |
2019: 11 services
| Replacement of knee joint, both sides of knee | 42 | $57,963 | $1,233 |
| Replacement of thigh bone and hip joint with prosthesis | 36 | $45,667 | $1,234 |
| Short return visit (20+ min) | 284 | $26,879 | $64 |
| Return visit (30+ min) | 219 | $26,090 | $97 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 51 | $22,628 | None |
| New patient visit (30+ min) | 150 | $13,864 | $92 |
| Aspiration and/or injection of fluid from large joint | 126 | $13,491 | $63 |
| New patient visit (45+ min) | 35 | $5,212 | $149 |
| Long return visit (40+ min) | 19 | $2,702 | $135 |
| Short return visit | 32 | $1,600 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 72 | $229 | None |
2018: 13 services
| Replacement of knee joint, both sides of knee | 32 | $43,595 | $1,211 |
| Replacement of thigh bone and hip joint with prosthesis | 34 | $40,778 | $1,199 |
| Return visit (30+ min) | 233 | $25,370 | $93 |
| Short return visit (20+ min) | 258 | $23,361 | $64 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 52 | $23,136 | None |
| Aspiration and/or injection of fluid from large joint | 155 | $15,770 | $64 |
| New patient visit (30+ min) | 138 | $12,571 | $91 |
| New patient visit (45+ min) | 69 | $9,731 | $141 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 70 | $8,858 | $92 |
| Destruction of peripheral nerve or branch | 11 | $2,614 | $54 |
| Short return visit | 54 | $2,546 | $40 |
| Long return visit (40+ min) | 12 | $1,632 | $136 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 144 | $728 | None |
2017: 11 services
| Replacement of thigh bone and hip joint with prosthesis | 33 | $41,495 | $1,220 |
| Replacement of knee joint, both sides of knee | 28 | $38,895 | $1,215 |
| Return visit (30+ min) | 225 | $22,853 | $95 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 57 | $22,713 | None |
| Aspiration and/or injection of fluid from large joint | 165 | $18,622 | $62 |
| Short return visit (20+ min) | 172 | $15,585 | $67 |
| New patient visit (30+ min) | 150 | $13,867 | $92 |
| New patient visit (45+ min) | 78 | $11,026 | $141 |
| Long return visit (40+ min) | 29 | $3,883 | $134 |
| Short return visit | 71 | $3,552 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 121 | $889 | None |
2016: 8 services
| New patient visit (30+ min) | 102 | $9,912 | $97 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 20 | $8,264 | None |
| Return visit (30+ min) | 73 | $7,912 | $98 |
| Aspiration and/or injection of fluid from large joint | 73 | $7,090 | $58 |
| Short return visit (20+ min) | 54 | $5,190 | $67 |
| New patient visit (45+ min) | 32 | $4,774 | $149 |
| Short return visit | 11 | $491 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | $362 | None |
2014: 11 services
| Replacement of knee joint, both sides of knee | 17 | $20,350 | $1,197 |
| Return visit (30+ min) | 93 | $9,132 | $86 |
| Short return visit (20+ min) | 78 | $6,384 | $61 |
| New patient visit (60+ min) | 26 | $4,460 | $172 |
| Aspiration and/or injection of fluid from large joint | 52 | $4,172 | $52 |
| New patient visit (45+ min) | 28 | $3,563 | $127 |
| Long return visit (40+ min) | 24 | $2,947 | $118 |
| X-ray of knee, 3 views | 60 | $2,320 | $34 |
| X-ray of ribs of one side of body, minimum of 2 views | 20 | $738 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 44 | $442 | None |
| X-ray of pelvis, 1-2 views | 11 | $284 | $26 |
2013: 16 services
| Replacement of knee joint, both sides of knee | 22 | $30,337 | $1,379 |
| Short return visit (20+ min) | 185 | $19,753 | $62 |
| Return visit (30+ min) | 121 | $13,366 | $96 |
| New patient visit (45+ min) | 75 | $10,545 | $141 |
| Aspiration and/or injection of fluid from large joint | 98 | $9,574 | $54 |
| X-ray of knee, 3 views | 107 | $5,735 | $38 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 14 | $5,684 | None |
| New patient visit (60+ min) | 23 | $4,177 | $182 |
| Long return visit (40+ min) | 32 | $3,948 | $123 |
| New patient visit (30+ min) | 25 | $2,178 | $87 |
| X-ray of ribs of one side of body, minimum of 2 views | 33 | $1,524 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $1,407 | None |
| X-ray of shoulder, minimum of 2 views | 25 | $1,004 | $30 |
| X-ray of pelvis, 1-2 views | 24 | $773 | $30 |
| X-ray of knee, 1-2 views | 11 | $452 | $30 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $369 | $34 |
Drugs they prescribed that Part D paid
$5,407
Pharmacies billed $5,407 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (44 of 217) in 2024. Above the middle of the specialty; the typical sports medicine clinician is at 15%.
214 generic and fewer than 11 brand-name prescriptions · $5,407 in drug cost · 104 antibiotic prescriptions to 90 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 13 | $737 | $57 |
| Amoxicillin | 77 | $261 | $3 |
| Oxycodone | 18 | $120 | $7 |
| Gabapentin | 18 | $84 | $5 |
| Tramadol | 19 | $76 | $4 |
See all 7 drugs
| Celecoxib | 13 | $737 | $57 |
| Amoxicillin | 77 | $261 | $3 |
| Oxycodone | 18 | $120 | $7 |
| Gabapentin | 18 | $84 | $5 |
| Tramadol | 19 | $76 | $4 |
| Clindamycin | 19 | $67 | $4 |
| Meloxicam | 12 | $18 | $1 |
Year by year
| 2024 | 217 | 144 | 20% (44) | None | $5,407 |
| 2023 | 177 | 127 | 11% (20) | None | $11,243 |
| 2022 | 216 | 129 | 28% (61) | None | $3,724 |
| 2021 | 178 | 118 | 29% (51) | None | $3,450 |
| 2020 | 242 | 158 | 24% (58) | None | $4,507 |
| 2019 | 270 | 139 | 40% (107) | None | $5,187 |
| 2018 | 135 | 89 | 28% (38) | 10% | $3,376 |
| 2017 | 174 | 90 | 50% (87) | 9% | $3,782 |
| 2016 | 71 | 38 | 59% (42) | None | $1,855 |
| 2015 | 45 | 19 | 58% (26) | None | $2,042 |
| 2014 | 162 | 56 | 40% (65) | 15% | $8,466 |
| 2013 | 287 | 90 | 55% (157) | 13% | $13,494 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Amoxicillin | 66 | $217 | $3 |
| Clindamycin | 16 | $79 | $5 |
2022: 4 drugs
| Oxycodone | 35 | $403 | $12 |
| Amoxicillin | 60 | $201 | $3 |
| Clindamycin | 16 | $76 | $5 |
| Tramadol | 18 | $48 | $3 |
2021: 5 drugs
| Diclofenac | 18 | $856 | $48 |
| Tramadol | 28 | $227 | $8 |
| Amoxicillin | 55 | $188 | $3 |
| Oxycodone | 13 | $160 | $12 |
| Clindamycin | 17 | $69 | $4 |
2020: 6 drugs
| Diclofenac | 62 | $2,922 | $47 |
| Celecoxib | 15 | $466 | $31 |
| Oxycodone | 16 | $157 | $10 |
| Amoxicillin | 43 | $148 | $3 |
| Tramadol | 39 | $129 | $3 |
| Clindamycin | 21 | $116 | $6 |
2019: 8 drugs
| Diclofenac | 27 | $1,406 | $52 |
| Celecoxib | 15 | $1,013 | $68 |
| Oxycodone | 57 | $869 | $15 |
| Hydrocodone-Acetaminophen | 14 | $202 | $14 |
| Amoxicillin | 42 | $186 | $4 |
| Tramadol | 35 | $165 | $5 |
| Clindamycin | 16 | $68 | $4 |
| Meloxicam | 14 | $58 | $4 |
2018: 5 drugs
| Celecoxib | 12 | $1,168 | $97 |
| Diclofenac | 14 | $800 | $57 |
| Hydrocodone-Acetaminophen | 17 | $292 | $17 |
| Oxycodone | 12 | $111 | $9 |
| Amoxicillin | 27 | $103 | $4 |
2017: 7 drugs
| Celecoxib | 17 | $1,385 | $81 |
| Voltaren | 11 | $676 | $61 |
| Oxycodone | 36 | $312 | $9 |
| Hydrocodone-Acetaminophen | 28 | $260 | $9 |
| Tramadol | 21 | $60 | $3 |
| Amoxicillin | 11 | $33 | $3 |
| Prednisone | 11 | $31 | $3 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 25 | $385 | $15 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 16 | $309 | $19 |
2014: 4 drugs
| Celebrex | 11 | $2,954 | $269 |
| Hydrocodone-Acetaminophen | 24 | $386 | $16 |
| Oxycodone-Acetaminophen | 21 | $335 | $16 |
| Amoxicillin | 30 | $86 | $3 |
2013: 8 drugs
| Enoxaparin | 13 | $4,027 | $310 |
| Celebrex | 14 | $2,993 | $214 |
| Hydrocodone-Acetaminophen | 85 | $802 | $9 |
| Tramadol Hcl-Acetaminophen | 11 | $612 | $56 |
| Diclofenac | 21 | $468 | $22 |
| Oxycodone-Acetaminophen | 25 | $234 | $9 |
| Roxicet | 17 | $154 | $9 |
| Amoxicillin | 18 | $54 | $3 |
Money from drug and device companies
$256 in 2025
| 2025 | 2 | 8 | None | $256 |
| 2024 | 1 | 2 | None | $296 |
| 2022 | 2 | 8 | None | $1,195 |
| 2021 | 4 | 13 | None | $1,481 |
| 2020 | 1 | 1 | None | $123 |
| 2019 | 6 | 8 | None | $522 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Exeter | $235 | 7 payments
|
| Medtronic | Aquamantys(Tm) | $21 | 1 payment
|
See all 8 published payments
| Medtronic | Meals · 2025-12-08 | Aquamantys(Tm) | $21 |
| Stryker | Meals · 2025-10-30 | Tbcem | $17 |
| Stryker | Meals · 2025-10-23 | Tbcem | $16 |
| Stryker | Meals · 2025-10-13 | Exeter | $70 |
| Stryker | Meals · 2025-10-13 | Exeter | $55 |
| Stryker | Meals · 2025-10-09 | 1788 | $39 |
| Stryker | Meals · 2025-09-23 | Tbcem | $19 |
| Stryker | Meals · 2025-07-10 | Tbcem | $19 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $296
| Stryker | Mako | $296 | 2 payments
|
2022: $1,195
| Stryker | Mako | $1,107 | 7 payments
|
| Zimmer Biomet Holdings | Persona | $88 | 1 payment
|
2021: $1,481
| Zimmer Biomet Holdings | Rosa-Knee | $590 | 6 payments
|
| DePuy Synthes Sales | Velys | $516 | 2 payments
|
| Stryker | Mako | $336 | 3 payments
|
| Medical Device Business Services | Attune | $39 | 2 payments
|
2020: $123
| Zimmer Biomet Holdings | Rosa-Knee | $123 | 1 payment
|
2019: $522
| Zimmer Biomet Holdings | Connected Health Product Portfolio | $257 | 2 payments
|
| Kci USA | Prevena | $109 | 1 payment
|
| Ethicon US | Stratafix | $96 | 2 payments
|
| Orthalign | Orthalign Plus System | $25 | 1 payment
|
| Avanos Medical | Coolief* Cooled Radiofrequency | $20 | 1 payment
|
| Vericel | Maci | $16 | 1 payment
|
Professional record
- NPI
- 1578737029
- Licence
- CA A104283California A104283: Current · expires 2028-06-30
- Trained
- Georgetown University School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2008-04-16
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.